Ramucirumab
Generic name: Ramucirumab
Brand names: Cyramza
Dosage form: intravenous solution (10 mg/mL)
Drug class:
VEGF/VEGFR inhibitors
Usage of Ramucirumab
Ramucirumab is used to treat stomach cancer, colorectal cancer, or non-small cell lung cancer that has spread to other parts of the body. Ramucirumab may be given alone or in combination with other cancer medicines.
Ramucirumab is usually given after other treatments have failed.
Ramucirumab may also be used for purposes not listed in this medication guide.
Ramucirumab side effects
Get emergency medical help if you have signs of an allergic Reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during the injection. Tell your caregiver right away if you feel light-headed, chilled, sweaty, or have chest pain, chest tightness, back pain, trouble breathing, or numbness and tingling.
Ramucirumab can increase your risk of serious bleeding.
Ramucirumab may cause serious side effects. Call your doctor at once if you have:
Common side effects of ramucirumab may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Ramucirumab
You should not use ramucirumab if you are allergic to it, or if you have:
Tell your doctor if you have ever HAD:
This medicine can harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine. Ramucirumab may affect fertility (your ability to have children).
Use birth control to prevent pregnancy while you are receiving ramucirumab, and for at least 3 months after your treatment ends.
You should not breastfeed while using this medicine.
Relate drugs
- Alymsys
- Alymsys (Bevacizumab Intravenous)
- Alymsys (Bevacizumab-maly Intravenous)
- Avastin
- Cyramza
- Mvasi
- Mvasi (Bevacizumab Intravenous)
- Mvasi (Bevacizumab-awwb Intravenous)
- Bevacizumab
- Bevacizumab-adcd
- Bevacizumab-awwb
- Bevacizumab-bvzr
- Bevacizumab-maly
- Fotivda
- Pazopanib
- Ramucirumab
- Tivozanib
- Vegzelma
- Vegzelma (Bevacizumab Intravenous)
- Vegzelma (Bevacizumab-adcd Intravenous)
- Votrient
- Zaltrap
- Zirabev
- Zirabev (Bevacizumab Intravenous)
- Zirabev (Bevacizumab-bvzr Intravenous)
- Ziv-aflibercept
How to use Ramucirumab
Ramucirumab is given as an infusion into a vein. A healthcare provider will give you this injection.
You may be given medication to prevent certain side effects while you are receiving ramucirumab.
Ramucirumab is sometimes given once every 2 weeks. Ramucirumab may also be given in a 21-Day treatment cycle and you may only need to use the medicine during the first day of each cycle. Follow your doctor's dosing instructions very carefully.
While using ramucirumab, you may need frequent blood or urine tests. Your blood pressure will need to be checked often.
If you need surgery, tell the surgeon ahead of time that you are using ramucirumab.
Warnings
Ramucirumab can increase your risk of serious bleeding. Stop using ramucirumab and call your doctor at once if you have severe stomach pain, bloody or tarry stools, coughing up blood, or any heavy or unusual bleeding.
What other drugs will affect Ramucirumab
Other drugs may affect ramucirumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions